JP2018531984A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531984A5 JP2018531984A5 JP2018522570A JP2018522570A JP2018531984A5 JP 2018531984 A5 JP2018531984 A5 JP 2018531984A5 JP 2018522570 A JP2018522570 A JP 2018522570A JP 2018522570 A JP2018522570 A JP 2018522570A JP 2018531984 A5 JP2018531984 A5 JP 2018531984A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- botulinum toxin
- component
- positively charged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021162802A JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562248255P | 2015-10-29 | 2015-10-29 | |
| US62/248,255 | 2015-10-29 | ||
| PCT/US2016/059492 WO2017075468A1 (en) | 2015-10-29 | 2016-10-28 | Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021162802A Division JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531984A JP2018531984A (ja) | 2018-11-01 |
| JP2018531984A5 true JP2018531984A5 (https=) | 2019-12-12 |
| JP6955491B2 JP6955491B2 (ja) | 2021-10-27 |
Family
ID=58630886
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522570A Active JP6955491B2 (ja) | 2015-10-29 | 2016-10-28 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
| JP2021162802A Pending JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021162802A Pending JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20180311333A1 (https=) |
| EP (1) | EP3368071B1 (https=) |
| JP (2) | JP6955491B2 (https=) |
| KR (1) | KR102794108B1 (https=) |
| CN (1) | CN109069608A (https=) |
| AU (2) | AU2016343748A1 (https=) |
| BR (1) | BR112018008684A2 (https=) |
| CA (1) | CA3003447A1 (https=) |
| CO (1) | CO2018005361A2 (https=) |
| DK (1) | DK3368071T3 (https=) |
| ES (1) | ES2907652T3 (https=) |
| IL (2) | IL259016A (https=) |
| MX (1) | MX2018005256A (https=) |
| RU (1) | RU2018119765A (https=) |
| SG (2) | SG11201803566TA (https=) |
| WO (1) | WO2017075468A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG160357A1 (en) * | 2005-03-03 | 2010-04-29 | Revance Therapeutics Inc | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| EP2445521A4 (en) | 2009-06-25 | 2015-08-26 | Revance Therapeutics Inc | ALBUMINE-FREE BOTULINUM TOXIN FORMULATIONS |
| PH12012500549A1 (en) * | 2009-10-21 | 2017-08-23 | Revance Therapeutics Inc | Methods and systems for purifying non-complexed botulinum neurotoxin |
| AU2016343748A1 (en) | 2015-10-29 | 2018-05-17 | Revance Therapeutics, Inc. | Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect |
| AU2017360346B2 (en) | 2016-11-21 | 2023-11-23 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| JP7604222B2 (ja) * | 2017-03-22 | 2024-12-23 | ボンチ インコーポレイテッド | 治療用のボツリヌス神経毒素 |
| MX2019013716A (es) | 2017-05-18 | 2020-10-12 | Revance Therapeutics Inc | Métodos de tratamiento para la distonía cervical. |
| EP3641746B1 (en) | 2017-06-19 | 2024-11-20 | President And Fellows Of Harvard College | Methods and compositions for treating a microbial infection |
| EP3675900A4 (en) | 2017-08-28 | 2021-05-05 | Revance Therapeutics, Inc. | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders |
| EP3703738A4 (en) * | 2017-11-03 | 2021-09-08 | ReVance Therapeutics, Inc. | BOTULINIC TOXIN FORMULATIONS AND METHODS OF USE THEREOF IN PLANTARY FASCIITIS, WITH EXTENDED DURATION OF EFFECT |
| SG11202005239YA (en) * | 2017-12-04 | 2020-07-29 | Revance Therapeutics Inc | Injectable botulinum toxin formulations and methods of use thereof having high response rate and long effect duration |
| AU2019337656A1 (en) * | 2018-09-13 | 2021-05-06 | Allergan, Inc. | Methods for treatment of masseter muscle hypertrophy |
| CA3139983A1 (en) * | 2019-05-14 | 2020-11-19 | Eirion Therapeutics, Inc. | Delaying peak effect and/or extending duration of response |
| US20230210963A1 (en) * | 2020-03-18 | 2023-07-06 | Revance Therapeutics, Inc. | Injectable botulinum toxin methos for treating headaches |
| KR102397708B1 (ko) * | 2020-04-29 | 2022-05-16 | 한국화학연구원 | 탄닌산을 포함하는 보툴리눔 독소 약제학적 조성물 |
| KR102324855B1 (ko) * | 2020-05-20 | 2021-11-11 | 오스템임플란트 주식회사 | 보툴리눔 독소를 포함하는 약제학적 액상 조성물 |
| KR20230086752A (ko) * | 2020-10-13 | 2023-06-15 | 레반스 테라퓨틱스, 아이엔씨. | 경부 근긴장이상증의 치료 방법 |
| KR102266384B1 (ko) * | 2021-01-25 | 2021-06-21 | 주식회사 울트라브이 | 필러용 생분해성 고분자 미세입자, 이를 포함한 필러용 동결건조체, 그 제조방법 및 상기 동결건조체를 포함하는 필러용 주사제 |
| US20250268996A1 (en) * | 2021-02-21 | 2025-08-28 | Revance Therapeutics, Inc. | Methods of and compositions for treatment of upper limb spasticity |
| US20240216487A1 (en) * | 2021-04-26 | 2024-07-04 | Shanghaitech University | Intramuscular compositions of botulinum neurotoxins |
| WO2023085849A1 (ko) * | 2021-11-15 | 2023-05-19 | (주)메디톡스 | 보툴리눔 독소 조성물 |
| EP4537850A1 (en) * | 2022-06-10 | 2025-04-16 | Medytox Inc. | Composition for stabilizing botulinum neurotoxin, botulinum neurotoxin formulation containing same, and polypeptides for use therein |
| KR102714765B1 (ko) * | 2023-05-04 | 2024-10-11 | 주식회사 파마리서치바이오 | Dna 단편 혼합물 및 보툴리눔 독소를 포함하는 보툴리눔 독소의 생체 내 지속성이 증가된 지속성 제제 |
| WO2025064729A1 (en) * | 2023-09-19 | 2025-03-27 | Revance Therapeutics, Inc. | Treatment with botulinum toxin in patients in need of a rapid onset cosmetic effect and smoother skin appearance |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877278A (en) | 1992-09-24 | 1999-03-02 | Chiron Corporation | Synthesis of N-substituted oligomers |
| US6444209B1 (en) | 1996-10-28 | 2002-09-03 | Wisconsin Alumni Research Foundation | Hybrid botulinal neurotoxins |
| ATE519494T1 (de) | 2000-02-08 | 2011-08-15 | Allergan Inc | Pharmazeutische zusammensetzungen mit botulinum- toxin |
| DE10043982A1 (de) * | 2000-09-05 | 2002-03-14 | Armin Maurer | Verfahren zur Verbesserung des Haarwuchses menschlichen Kopfhaares |
| GB2416122A (en) | 2004-07-12 | 2006-01-18 | Ipsen Ltd | Botulinum neurotoxin composition |
| AU2009332947C1 (en) | 2008-12-31 | 2019-01-03 | Revance Therapeutics, Inc. | Injectable botulinum toxin formulations |
| EP2445521A4 (en) | 2009-06-25 | 2015-08-26 | Revance Therapeutics Inc | ALBUMINE-FREE BOTULINUM TOXIN FORMULATIONS |
| PT2661276T (pt) * | 2011-01-07 | 2017-10-06 | Revance Therapeutics Inc | Composição tópica que inclui uma tóxina botulínica e um corante |
| AU2013234988A1 (en) | 2012-03-22 | 2014-10-09 | Revance Therapeutics, Inc. | Method of treatment of wrinkles using topical chemodenervating agents |
| CA2889833A1 (en) * | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and methods for safe treatment of rhinitis |
| AU2016343748A1 (en) | 2015-10-29 | 2018-05-17 | Revance Therapeutics, Inc. | Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect |
-
2016
- 2016-10-28 AU AU2016343748A patent/AU2016343748A1/en not_active Abandoned
- 2016-10-28 WO PCT/US2016/059492 patent/WO2017075468A1/en not_active Ceased
- 2016-10-28 RU RU2018119765A patent/RU2018119765A/ru not_active Application Discontinuation
- 2016-10-28 KR KR1020187014681A patent/KR102794108B1/ko active Active
- 2016-10-28 ES ES16860952T patent/ES2907652T3/es active Active
- 2016-10-28 US US15/771,635 patent/US20180311333A1/en not_active Abandoned
- 2016-10-28 SG SG11201803566TA patent/SG11201803566TA/en unknown
- 2016-10-28 DK DK16860952.7T patent/DK3368071T3/da active
- 2016-10-28 EP EP16860952.7A patent/EP3368071B1/en active Active
- 2016-10-28 SG SG10202004337WA patent/SG10202004337WA/en unknown
- 2016-10-28 JP JP2018522570A patent/JP6955491B2/ja active Active
- 2016-10-28 BR BR112018008684-3A patent/BR112018008684A2/en active Search and Examination
- 2016-10-28 MX MX2018005256A patent/MX2018005256A/es unknown
- 2016-10-28 CA CA3003447A patent/CA3003447A1/en active Pending
- 2016-10-28 CN CN201680072956.XA patent/CN109069608A/zh active Pending
-
2018
- 2018-04-29 IL IL259016A patent/IL259016A/en unknown
- 2018-05-23 CO CONC2018/0005361A patent/CO2018005361A2/es unknown
-
2021
- 2021-09-10 US US17/472,525 patent/US20220062400A1/en active Pending
- 2021-09-19 IL IL286472A patent/IL286472A/en unknown
- 2021-10-01 JP JP2021162802A patent/JP2022008814A/ja active Pending
-
2023
- 2023-10-06 AU AU2023241373A patent/AU2023241373A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018531984A5 (https=) | ||
| RU2018119765A (ru) | Инъекционные препараты на основе ботулотоксина и способы их применения, обеспечивающие длительное терапевтическое и косметического действие | |
| JP2016540785A5 (https=) | ||
| FI3506886T3 (fi) | Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä | |
| HRP20241127T1 (hr) | Formulacije i doze pegilirane urikaze | |
| JP2015517488A5 (https=) | ||
| JP2015231997A5 (https=) | ||
| WO2009046824A3 (en) | Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis | |
| HRP20251088T1 (hr) | Upotreba dugodjelujućih peptida glp‑1 | |
| WO2009033668A3 (en) | Use of a peptide as a therapeutic agent | |
| WO2009040068A3 (en) | Use of a peptide as a therapeutic agent | |
| JP2018505882A5 (https=) | ||
| JP2016539921A5 (https=) | ||
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| WO2009033736A3 (en) | Use of met-enkephalin as a therapeutic agent | |
| JP2019509311A5 (https=) | ||
| WO2009033712A3 (en) | Use of melanotan ii as a therapeutic agent | |
| IL307992A (en) | Parasitic formulations containing isoxazoline and methods for treating blepharitis | |
| HRP20230300T1 (hr) | Kombinacije imetelstata i venetoklaksa za liječenje akutne mijeloidne leukemije | |
| JP2013532729A5 (https=) | ||
| WO2009033791A3 (en) | Use of a peptide as a therapeutic agent | |
| RU2016137292A (ru) | Схема применения соединения fgf-18 | |
| JP2015520196A5 (https=) | ||
| JP2017512194A5 (https=) | ||
| RU2018125622A (ru) | Способ применения карримицина против резистетности инфекции, спровоцированной микобактерией туберкулеза |